CBAN trades at Wall Street's consensus target of —.
Last 12 months price action with 12-month analyst target path
The base valuation assumes CBAN achieves its forward estimates and maintains a stable P/E multiple of 9.8x. This scenario reflects the blended consensus of 2 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of November 8, 2026, Colony Bankcorp, Inc. (CBAN) has a Wall Street consensus price target of N/A, based on estimates from 2 covering analysts. The company has a market capitalization of $428M.
Analyst price targets range from a low of N/A to a high of N/A.
The current analyst consensus rating is Hold, with 0 analysts rating the stock as a Buy or Strong Buy,2 rating it Hold, and 0 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, CBAN trades at a trailing P/E of 11.5x and forward P/E of 9.8x. The forward PEG ratio of 1.92 indicates reasonable valuation for growth. Analysts expect EPS to grow +34.1% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $25.11, with bear and bull scenarios of $15.82 and $33.09 respectively. Model confidence stands at 42/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 SBCFSeacoast Banking Corporation of Florida | $3.3B | $33.54 | $35.75 | +6.6% | Hold | 13.2x | 16 |
 HOMBHome Bancshares, Inc. | $6.0B | $29.86 | $33.67 | +12.8% | Hold | 11.8x | 19 |
 SFBSServisFirst Bancshares, Inc. | $4.5B | $41.08 | $45.50 | +10.8% | Buy | 12.9x | 6 |
 HBCPHome Bancorp, Inc. | $479M | $60.94 | $65.00 | +6.7% | Buy | 10.8x | 3 |
 CZWICitizens Community Bancorp, Inc. | $225M | $23.38 | $24.00 | +2.7% | Buy | 15.0x | 3 |
 FFINFirst Financial Bankshares, Inc. | $4.4B | $30.41 | $34.33 | +12.9% | Hold | 14.9x | 17 |
 GABCGerman American Bancorp, Inc. | $1.9B | $50.08 | $60.00 | +19.8% | Hold | 12.7x | 8 |
 NBTBNBT Bancorp Inc. | $2.7B | $52.83 | $57.67 | +9.2% | Hold | 12.6x | 10 |
 SRCE1st Source Corporation | $2.1B | $86.94 | $96.00 | +10.4% | Hold | 11.4x | 4 |
 FBNCFirst Bancorp | $2.7B | $64.60 | $68.00 | +5.3% | Buy | 13.7x | 16 |
Quick answers to the most common questions about buying CBAN stock.
The consensus price target for CBAN is $N/A, close to the current price of $20.24 (N/A% implied move). Based on 2 analyst estimates, the stock appears fairly valued near current levels.
CBAN has a consensus rating of "Hold" based on 2 Wall Street analysts. The rating breakdown is mixed, with 2 Hold ratings making up the largest segment. The consensus 12-month price target of $N/A implies N/A% upside from current levels.
With a forward P/E of 9.7778x, CBAN trades at a relatively low valuation. The consensus target of $N/A implies N/A% appreciation, suggesting the market may be pricing in risks.
The most bullish Wall Street analyst has a price target of $N/A for CBAN, while the most conservative target is $N/A. The consensus of $N/A represents the median expectation. Our quantitative valuation model projects a bull case target of $33 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
CBAN is lightly followed, with 2 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 0 have Buy ratings, 2 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month CBAN stock forecast based on 2 Wall Street analysts shows a consensus price target of $N/A, with estimates ranging from $N/A (bear case) to $N/A (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $25, with bear/bull scenarios of $16/$33.
Our quantitative valuation model calculates CBAN's fair value at $25 (base case), with a bear case of $16 and bull case of $33. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 42/100.
CBAN trades at a forward P/E ratio of 9.8x based on next-twelve-months earnings estimates compared to a trailing P/E of 11.5x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
CBAN appears fairly valued according to analysts, with a "Hold" rating and minimal upside to the $N/A target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
CBAN analyst price targets range from $N/A to $N/A, a NaN% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $N/A consensus represents the middle ground. Our model's $16-$33 range provides an independent fundamental perspective.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.